Skip to content Skip to Search
Skip navigation

PIF’s Lifera and Sanofi join hands to produce vaccines

Person, Human, Clinic REUTERS/Kim Kyung-Hoon
Lifera and Sanofi will collaborate to boost Saudi Arabia’s vaccines localisation strategy

A subsidiary of Saudi Arabia’s sovereign wealth fund has signed an agreement to increase the local production of vaccines.

Lifera, wholly owned by the Public Investment Fund (PIF), French pharma major Sanofi and Arabio, majority owned by Riyadh-based Tamer Group, will set up manufacturing facilities in the kingdom to produce vaccines for Saudi citizens.

No details were given on the location of the facilities or total investment. 

As part of the agreement, Lifera and Sanofi will collaborate to boost Saudi Arabia’s vaccines localisation strategy, with Lifera becoming a contract manufacturer to Sanofi.

The two entities will use Arabio to supply vaccines and other biopharmaceutical products across the local market.

The PIF last month launched Lifera to make life-saving and essential products, including insulins, vaccines and plasma therapeutics. 

The Saudi pharmaceutical industry was valued at SAR44 billion ($11.7 billion) last year, according to BMI, and is forecast to grow at an annual rate of over 5 percent to $15.1 billion in 2027 and $19.8 billion in 2032. 

Several multinational companies have already established a presence in the country, either through direct investment or partnerships with local companies, including Novartis, Pfizer, Sanofi, Merck and GlaxoSmithKline. 

Sanofi has been producing vaccines for over a century now. Every year, over half a billion people are vaccinated with Sanofi’s vaccines worldwide, including more than 10 million in the Gulf region. 

In 2022, the French pharma firm distributed more than six million doses of its quadrivalent influenza vaccine in the region. Globally through its research and development efforts, it aims to bring 10 new vaccine candidates into clinical trials by 2025. 

Latest articles

Microsoft president Brad Smith and G42 CEO Peng Xiao (right) sign the $1.5bn investment deal in the presence of G42 chairman Sheikh Tahnoon bin Zayed Al Nahyan

Microsoft invests in UAE’s AI leader G42 

The US tech giant Microsoft will invest $1.5 billion in the Abu Dhabi-based artificial intelligence (AI) company G42 to help accelerate its global expansion strategy. As part of the deal G42 will run its AI applications and services on Azure, Microsoft’s cloud computing platform. Brad Smith, vice-chair and president of Microsoft, will join the G42 […]

Spinneys CEO Sunil Kumar and chairman Ali Al Bwardy. The company operates 75 grocery retail supermarkets in the UAE and Oman

Spinneys to offer 900m shares in Dubai IPO

Supermarket operator Spinneys will sell 25 percent of its business in an initial public offering (IPO) on the Dubai Financial Market (DFM), according to an intention to float document released on Tuesday. The company’s offering will be open from April 23 to April 29 for retail investors, while institutional investors can subscribe until April 30, according […]

The number of international passengers at DXB reached nearly 87 million in 2023, rising 32% from the previous year

DXB remains world’s busiest international airport

Dubai International (DXB) has maintained its status as the world’s busiest international airport, beating London and Amsterdam, the Airports Council International (ACI), an association of world airports, said in a new report. DXB has secured the top place for the 10th consecutive year, with the number of international passengers reaching nearly 87 million in 2023, […]

Real GDP growth projection for the UAE was revised to 3.9 percent this year, up from 3.7 percent

World Bank raises UAE’s economic growth outlook

The World Bank has raised its UAE economic growth forecast for 2024 and 2025, citing robust non-oil sector growth and higher oil output. The real GDP growth projection for the Gulf state was revised to 3.9 percent this year, up from its previous forecast of 3.7 percent in January, the World Bank said in its […]